Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

March 9, 2011
Aeterna Zentaris, Inc. and Yakult Honsha Co. have signed an exclusive development, commercialization and licensing agreement for Aeterna Zentaris' lead anti-cancer compound perifosine, in Japan.   Read More »
March 8, 2011
RainDance Technologies, Inc. and Ambry Genetics have entered a collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel.   Read More »
March 7, 2011
Bristol-Myers Squibb and WuXi PharmaTech have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications.   Read More »
March 3, 2011
Lycera Corp. and Merck have entered into an exclusive research collaboration to discover, develop and commercialize drug candidates to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis.   Read More »
March 3, 2011
Ricerca Biosciences has entered a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, to provide value-added capabilities to biopharma companies by creating a streamlined and efficient process to move a drug candidate from development t   Read More »
March 2, 2011
IRX Therapeutics has signed a research collaboration agreement with a leading research-based pharmaceutical company to assess the potential effects of IRX-2 on the tumor microenvironment.   Read More »
March 2, 2011
PTC Therapeutics, through its Wellcome Trust collaboration, has identified a chemical series of molecules that penetrates the blood-brain barrier in animal models and reduces levels of BMI1, a protein linked to drug-resistant cancers.   Read More »
March 1, 2011
Amatsi (formerly known as CRID Pharma) and Avogadro will join forces in an effort to provide a broader range of drug development services to their respective pharma and biopharma clients.   Read More »
February 28, 2011
Pilgrim Software, Inc. and QPharma, Inc. have agreed to make QPharma’s set of validation, quality and regulatory compliance consulting services available to customers in collaboration with Pilgrim’s SmartSolve suite of products.   Read More »
February 25, 2011
Ipsen and bioMérieux have entered into a global collaboration around theranostics (personalized diagnostic medicine), with a focus on hormone-dependent cancers.   Read More »
February 24, 2011
Prasco Laboratories has signed a distribution and supply agreement with Shire US Manufacturing, Inc. for mesalamine controlled-release capsules.   Read More »
February 23, 2011
Elan and PPD, Inc. have formed a global business collaboration focused on advancing the development of Elan’s portfolio.   Read More »
February 23, 2011
Ingenuity Systems has entered a research collaboration with Covance Genomics Laboratory for next-generation sequencing (NGS) data analysis.   Read More »
February 22, 2011
MorphoSys AG has received a milestone payment from Novartis for the installation of its HuCAL antibody platform at Novartis Institutes for BioMedical Research in Basel, Switzerland.   Read More »
February 16, 2011
BioConvergence and Creapharm have partnered in an effort to provide customers with lower costs, reduced risks, and increased control of projects.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On